Literature DB >> 16221668

Crystal structure of the FERM domain of focal adhesion kinase.

Derek F J Ceccarelli1, Hyun Kyu Song, Florence Poy, Michael D Schaller, Michael J Eck.   

Abstract

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that localizes to focal adhesions in adherent cells. Through phosphorylation of proteins assembled at the cytoplasmic tails of integrins, FAK promotes signaling events that modulate cellular growth, survival, and migration. The amino-terminal region of FAK contains a region of sequence homology with band 4.1 and ezrin/radixin/moesin (ERM) proteins termed a FERM domain. FERM domains are found in a variety of signaling and cytoskeletal proteins and are thought to mediate intermolecular interactions with partner proteins and phospholipids at the plasma membrane and intramolecular regulatory interactions. Here we report two crystal structures of an NH2-terminal fragment of avian FAK containing the FERM domain and a portion of the regulatory linker that connects the FERM and kinase domains. The tertiary folds of the three subdomains (F1, F2, and F3) are similar to those of known FERM structures despite low sequence conservation. Differences in the sequence and relative orientation of the F3 subdomain alters the nature of the interdomain interface, and the phosphoinositide binding site found in ERM family FERM domains is not present in FAK. A putative protein interaction site on the F3 lobe is masked by the proximal region of the linker. Additionally, in one structure the adjacent Src SH3 and SH2 binding sites in the linker associate with the surfaces of the F3 and F1 lobes, respectively. These structural features suggest the possibility that protein interactions of the FAK FERM domain can be regulated by binding of Src kinases to the linker segment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221668     DOI: 10.1074/jbc.M509188200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo.

Authors:  Vita M Golubovskaya; Sheila Figel; Baotran T Ho; Christopher P Johnson; Michael Yemma; Grace Huang; Min Zheng; Carl Nyberg; Andrew Magis; David A Ostrov; Irwin H Gelman; William G Cance
Journal:  Carcinogenesis       Date:  2012-03-07       Impact factor: 4.944

2.  Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain.

Authors:  Qianzhi Li; Mark R Nance; Rima Kulikauskas; Kevin Nyberg; Richard Fehon; P Andrew Karplus; Anthony Bretscher; John J G Tesmer
Journal:  J Mol Biol       Date:  2006-10-26       Impact factor: 5.469

3.  Structure of dimerized radixin FERM domain suggests a novel masking motif in C-terminal residues 295-304.

Authors:  Ken Kitano; Fumie Yusa; Toshio Hakoshima
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-03-25

4.  Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.

Authors:  Timothy A Marlowe; Felicia L Lenzo; Sheila A Figel; Abigail T Grapes; William G Cance
Journal:  Mol Cancer Ther       Date:  2016-09-16       Impact factor: 6.261

Review 5.  DENN domain proteins: regulators of Rab GTPases.

Authors:  Andrea L Marat; Hatem Dokainish; Peter S McPherson
Journal:  J Biol Chem       Date:  2011-02-17       Impact factor: 5.157

6.  Structural basis for the autoinhibition of focal adhesion kinase.

Authors:  Daniel Lietha; Xinming Cai; Derek F J Ceccarelli; Yiqun Li; Michael D Schaller; Michael J Eck
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

Review 7.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

8.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

Authors:  Vita M Golubovskaya; Carl Nyberg; Min Zheng; Frederick Kweh; Andrew Magis; David Ostrov; William G Cance
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

Review 9.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

10.  Structure of a double ubiquitin-like domain in the talin head: a role in integrin activation.

Authors:  Benjamin T Goult; Mohamed Bouaouina; Paul R Elliott; Neil Bate; Bipin Patel; Alexandre R Gingras; J Günter Grossmann; Gordon C K Roberts; David A Calderwood; David R Critchley; Igor L Barsukov
Journal:  EMBO J       Date:  2010-02-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.